The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis.

PubWeight™: 1.13‹?› | Rank: Top 10%

🔗 View Article (PMID 10674369)

Published in J Investig Dermatol Symp Proc on December 01, 1999

Authors

B W Colombe1, C D Lou, V H Price

Author Affiliations

1: Thomas Jefferson University Department of Medicine and Hospital, Philadelphia, Pennsylvania 19107, USA. Beth.Colombe@mail.tju.edu

Articles citing this

Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest (2007) 1.56

Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun (2015) 1.32

What causes alopecia areata? Exp Dermatol (2013) 1.14

Genetic basis of alopecia areata: a roadmap for translational research. Dermatol Clin (2012) 1.03

A gene for hypotrichosis simplex of the scalp maps to chromosome 6p21.3. Am J Hum Genet (2000) 0.92

Genome-wide pooling approach identifies SPATA5 as a new susceptibility locus for alopecia areata. Eur J Hum Genet (2011) 0.92

Serum Interleukin-4 and Total Immunoglobulin E in Nonatopic Alopecia Areata Patients and HLA-DRB1 Typing. Dermatol Res Pract (2010) 0.82

Association analysis of the HLA-C gene in Japanese alopecia areata. Immunogenetics (2013) 0.80

Clinical characteristics and prognostic factors in early-onset alopecia totalis and alopecia universalis. J Korean Med Sci (2012) 0.78

Drug discovery for alopecia: gone today, hair tomorrow. Expert Opin Drug Discov (2015) 0.75

Co-existent Presence of Alopecia Areata in Siblings: A Rare Presentation. Int J Trichology (2014) 0.75

Lack of association between alopecia areata and HLA class I and II in a southeastern Brazilian population. An Bras Dermatol (2016) 0.75

Review. Gastroenterol Hepatol (N Y) (2007) 0.75

Severe subtype of alopecia areata is highly associated with thyroid autoimmunity. Saudi Med J (2016) 0.75

Alopecia areata. Nat Rev Dis Prim (2017) 0.75

Articles by these authors

Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study Group. J Am Acad Dermatol (1998) 2.68

Psychological effects of androgenetic alopecia on women: comparisons with balding men and with female control subjects. J Am Acad Dermatol (1993) 1.39

Trichothiodystrophy: sulfur-deficient brittle hair as a marker for a neuroectodermal symptom complex. Arch Dermatol (1980) 1.38

Two individuals with features of both xeroderma pigmentosum and trichothiodystrophy highlight the complexity of the clinical outcomes of mutations in the XPD gene. Hum Mol Genet (2001) 1.33

Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia. J Invest Dermatol (1997) 1.25

Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol (1999) 1.18

HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol (1995) 1.03

Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol (1987) 1.01

Recalcitrant scarring follicular disorders treated by laser-assisted hair removal: a preliminary report. Dermatol Surg (1999) 1.00

Hormone replacement therapy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis. J R Soc Med (1990) 1.00

Hair regrowth. Therapeutic agents. Dermatol Clin (1998) 0.94

Testosterone metabolism in the skin. A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens. Arch Dermatol (1975) 0.87

HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol (1988) 0.86

Pili annulati. Optical and electron microscopic studies. Arch Dermatol (1968) 0.86

Cuticle cell defects in lamellar ichthyosis hair and anomalous hair shaft syndromes visualized after detergent extraction. Anat Rec (1996) 0.84

Noninfectious hair disorders in children. Curr Opin Pediatr (1996) 0.84

HLA class II alleles in long-standing alopecia totalis/alopecia universalis and long-standing patchy alopecia areata differentiate these two clinical groups. J Invest Dermatol (1995) 0.83

Guidelines of care for androgenetic alopecia. American Academy of Dermatology. J Am Acad Dermatol (1996) 0.82

Woolly hair associated with loose anagen hair. Acta Derm Venereol (2001) 0.82

The "hairless" gene in mouse and man. Arch Dermatol (1999) 0.81

Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants. Clin Transplant (2000) 0.80

Effect of ischemia-reperfusion on lipid digestion and absorption in rat intestine. Am J Physiol (1991) 0.80

Hair shaft defects visualized after detergent extraction. Exp Dermatol (1999) 0.80

Circadian rhythm of ornithine decarboxylase activity in small intestine of fasted rats. Proc Soc Exp Biol Med (1992) 0.78

Ornithine decarboxylase is involved in repair of small intestine after ischemia-reperfusion in rats. Am J Physiol (1991) 0.78

Trichothiodystrophy: clinical spectrum, central nervous system imaging, and biochemical characterization of two siblings. J Invest Dermatol (1994) 0.78

Topical minoxidil (3%) in extensive alopecia areata, including long-term efficacy. J Am Acad Dermatol (1987) 0.78

T cell repertoire in mice with alopecia areata. J Investig Dermatol Symp Proc (1999) 0.77

Eyebrow regrowth in patients with frontal fibrosing alopecia treated with intralesional triamcinolone acetonide. Br J Dermatol (2010) 0.77

Dermatology: minoxidil. West J Med (1985) 0.77

Treatment of hirsutism with cimetidine. Obstet Gynecol (1990) 0.76

No cell-surface-reactive antibodies against cultured autologous melanocytes found in alopecia areata sera. J Invest Dermatol (1995) 0.76

Topical minoxidil in alopecia areata: no effect on the perifollicular lymphoid infiltration. J Invest Dermatol (1992) 0.76

Anatomic, functional, and pathologic changes from internal ureteral stent placement. Urology (1992) 0.75

Authors' conflicts of interest: a disclosure and editors' reply. N Engl J Med (1999) 0.75

Treatment of androgenetic alopecia. West J Med (1989) 0.75

T-cell receptor repertoire V beta in alopecia areata. J Invest Dermatol (1995) 0.75

Two patterns of sensitization demonstrated by recipients of donor-specific transfusion. Limitations to control by Imuran. Transplantation (1987) 0.75

Trichothiodystrophy: an electron-histochemical study of the hair shaft. Br J Dermatol (1984) 0.75

Management of hair problems. Int J Dermatol (1979) 0.75

Disorders of the hair in children. Pediatr Clin North Am (1978) 0.75

Hormonal control of baldness. Int J Dermatol (1976) 0.75

An analysis of discrepancies in HLA phenotypes of cadaver donors in the united network for organ sharing registry. Transplantation (1997) 0.75

Pseudopili annulati; an unusual variant of normal hair. Arch Dermatol (1970) 0.75